Understand the source comparison
Comparison: immune peptide selection guide
Different immune goals require different peptide selections. This comparison helps match peptides to specific situations. Peptide Primary Mechanism Best For Evidence Quality Administration Cost Level Thymosin Alpha-1 T cell enhancement General immune support,
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different immune goals require different peptide selections. This comparison helps match peptides to specific situations.
- Peptide
- Primary Mechanism
- Best For
- Evidence Quality
- Administration
- Cost Level
- Thymosin Alpha-1
- T cell enhancement
- General immune support, viral infections
- Extensive clinical
- Subcutaneous
- High
- LL-37
- Direct antimicrobial
- Bacterial/viral infections, biofilms
- Strong preclinical
- Subcutaneous/local
- Medium
- Selank
- Immunomodulation + anxiolysis
- Stress-related immune dysfunction
- Clinical (Russia)
- Intranasal/SC
- Low-Medium
- KPV
- Anti-inflammatory
- Gut inflammation, autoimmune support
- Moderate preclinical
- Oral/SC
- BPC-157
- Gut healing, anti-inflammatory
- Gut-immune dysfunction
- Low
- TB-500
- Tissue healing
- Barrier maintenance, inflammation
- Semax
- Neuro + immune modulation
- Cognitive + immune goals
- Intranasal
- Thymalin
- Thymic support
- Age-related immune decline
- Clinical (Russia/EU)
- Intramuscular
- Evidence quality ratings consider both quantity and accessibility of research. "Clinical" indicates human trials exist, while "preclinical" indicates primarily animal and in vitro research.